Intraocular Lens (IOL) Market Size, Share, & Trends Analysis Report: By Product, By End Use (Hospitals, Ophthalmic Clinics, Ambulatory Surgery Centers, and Eye Research Institutes), and By Region – Market Forecast, 2025–2034
Description
The intraocular lens market size is expected to reach USD 7.59 billion by 2034, according to a new study by Polaris Market Research. The report “Intraocular Lens (IOL) Market Size, Share, & Trends Analysis Report: By Product, By End Use (Hospitals, Ophthalmic Clinics, Ambulatory Surgery Centers, and Eye Research Institutes), and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
An intraocular lens (IOL) is an artificial lens implanted in the eye to replace the eye’s natural lens when it is removed during cataract surgery.
More patients today are choosing premium IOLs such as multifocal, toric, and extended depth-of-focus lenses as they provide better vision outcomes and reduce the need for eyeglasses after surgery. As awareness grows and patients become more involved in their treatment choices, they are willing to pay more for lenses that improve their quality of life. Additionally, health insurance in many countries is expanding to cover part of the cost of these lenses. This shift in patient preference and payment capability boosts the market for premium IOLs, encouraging companies to invest in research and offer differentiated, higher-value products.
Today’s patients are not just looking to fix cataracts; they want better overall vision without relying on glasses or contact lenses. Many people also want to correct issues such as astigmatism or presbyopia during their cataract surgery, making refractive IOLs more popular. Younger patients undergoing lens replacement surgery for lifestyle reasons, such as correcting high myopia or enhancing vision quality, are also increasing. This shift from purely medical needs to lifestyle-driven choices expands the market for premium IOLs. As more people view good vision as part of overall well-being and appearance, the demand for advanced lenses continues to grow.
Intraocular Lens Market Report Highlights
Based on product, in 2024, the multifocal intraocular lenses segment dominated with the largest share due to their ability to improve vision at multiple distances, such as near, intermediate, and far.
The Ambulatory Surgery Centers (ASCs) segment, by end use, is expected to record the fastest growth during the forecast period due to their efficiency, cost-effectiveness, and shorter patient wait times.
In 2024, the North America IOL market dominated with the largest share due to advanced healthcare infrastructure, high awareness about eye health, and a large aging population prone to cataracts.
The Asia Pacific intraocular lens market is experiencing significant growth, driven by a large population base, increasing healthcare investments, and rising awareness about cataract treatments.
A few global key market players are Alcon, Inc.; Bausch & Lomb Incorporated; Carl Zeiss Meditec AG; EyeKon Medical, Inc.; HOYA CORPORATION; HumanOptics AG; Johnson and Johnson Vision Care, Inc.; Lenstec, Inc.; Rayner; and STAAR Surgical Company.
Polaris Market Research has segmented the intraocular lens market report on the basis of product, end use, and region:
By Product (Revenue – USD Billion, 2020–2034)
Monofocal Intraocular Lens
Multifocal Intraocular Lens
Toric Intraocular Lens
Accommodative Intraocular Lens
By End Use (Revenue – USD Billion, 2020–2034)
Hospitals
Ophthalmic Clinics
Ambulatory Surgery Centers
Eye Research Institutes
By Regional Outlook (Revenue – USD Billion, 2020–2034)
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
An intraocular lens (IOL) is an artificial lens implanted in the eye to replace the eye’s natural lens when it is removed during cataract surgery.
More patients today are choosing premium IOLs such as multifocal, toric, and extended depth-of-focus lenses as they provide better vision outcomes and reduce the need for eyeglasses after surgery. As awareness grows and patients become more involved in their treatment choices, they are willing to pay more for lenses that improve their quality of life. Additionally, health insurance in many countries is expanding to cover part of the cost of these lenses. This shift in patient preference and payment capability boosts the market for premium IOLs, encouraging companies to invest in research and offer differentiated, higher-value products.
Today’s patients are not just looking to fix cataracts; they want better overall vision without relying on glasses or contact lenses. Many people also want to correct issues such as astigmatism or presbyopia during their cataract surgery, making refractive IOLs more popular. Younger patients undergoing lens replacement surgery for lifestyle reasons, such as correcting high myopia or enhancing vision quality, are also increasing. This shift from purely medical needs to lifestyle-driven choices expands the market for premium IOLs. As more people view good vision as part of overall well-being and appearance, the demand for advanced lenses continues to grow.
Intraocular Lens Market Report Highlights
Based on product, in 2024, the multifocal intraocular lenses segment dominated with the largest share due to their ability to improve vision at multiple distances, such as near, intermediate, and far.
The Ambulatory Surgery Centers (ASCs) segment, by end use, is expected to record the fastest growth during the forecast period due to their efficiency, cost-effectiveness, and shorter patient wait times.
In 2024, the North America IOL market dominated with the largest share due to advanced healthcare infrastructure, high awareness about eye health, and a large aging population prone to cataracts.
The Asia Pacific intraocular lens market is experiencing significant growth, driven by a large population base, increasing healthcare investments, and rising awareness about cataract treatments.
A few global key market players are Alcon, Inc.; Bausch & Lomb Incorporated; Carl Zeiss Meditec AG; EyeKon Medical, Inc.; HOYA CORPORATION; HumanOptics AG; Johnson and Johnson Vision Care, Inc.; Lenstec, Inc.; Rayner; and STAAR Surgical Company.
Polaris Market Research has segmented the intraocular lens market report on the basis of product, end use, and region:
By Product (Revenue – USD Billion, 2020–2034)
Monofocal Intraocular Lens
Multifocal Intraocular Lens
Toric Intraocular Lens
Accommodative Intraocular Lens
By End Use (Revenue – USD Billion, 2020–2034)
Hospitals
Ophthalmic Clinics
Ambulatory Surgery Centers
Eye Research Institutes
By Regional Outlook (Revenue – USD Billion, 2020–2034)
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Table of Contents
129 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Intracranial Aneurysm Market Insights
- 4.1. Intracranial Aneurysm Market – Market Snapshot
- 4.2. Intracranial Aneurysm Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Prevalence of Intracranial Aneurysms
- 4.2.1.2. Advancements in Neurovascular Imaging Technologies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Limited awareness
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Intracranial Aneurysm Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Intracranial Aneurysm Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 5.3. Surgical Clipping
- 5.3.1. Global Intracranial Aneurysm Market, by Surgical Clipping, by Region, 2020–2034 (USD Million)
- 5.4. Endovascular Coiling
- 5.4.1. Global Intracranial Aneurysm Market, by Endovascular Coiling, by Region, 2020–2034 (USD Million)
- 5.5. Flow Diverters
- 5.5.1. Global Intracranial Aneurysm Market, by Flow Diverters, by Region, 2020–2034 (USD Million)
- 5.6. Others
- 5.6.1. Global Intracranial Aneurysm Market, by Others, by Region, 2020–2034 (USD Million)
- 6. Global Intracranial Aneurysm Market, by End-Use
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 6.3. Hospitals
- 6.3.1. Global Intracranial Aneurysm Market, by Hospitals, by Region, 2020–2034 (USD Million)
- 6.4. Clinics
- 6.4.1. Global Intracranial Aneurysm Market, by Clinics, by Region, 2020–2034 (USD Million)
- 6.5. Others
- 6.5.1. Global Intracranial Aneurysm Market, by Others, by Region, 2020–2034 (USD Million)
- 7. Global Intracranial Aneurysm Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Intracranial Aneurysm Market Assessment, By Geography, 2020–2034 (USD Million)
- 7.3. Intracranial Aneurysm Market – North America
- 7.3.1. North America: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.3.2. North America: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.3.3. Intracranial Aneurysm Market – U.S.
- 7.3.3.1. U.S.: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.3.3.2. U.S.: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.3.4. Intracranial Aneurysm Market – Canada
- 7.3.4.1. Canada: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.3.4.2. Canada: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.4. Intracranial Aneurysm Market – Europe
- 7.4.1. Europe: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.4.2. Europe: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.4.3. Intracranial Aneurysm Market – UK
- 7.4.3.1. UK: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.4.3.2. UK: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.4.4. Intracranial Aneurysm Market – France
- 7.4.4.1. France: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.4.4.2. France: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.4.5. Intracranial Aneurysm Market – Germany
- 7.4.5.1. Germany: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.4.5.2. Germany: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.4.6. Intracranial Aneurysm Market – Italy
- 7.4.6.1. Italy: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.4.6.2. Italy: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.4.7. Intracranial Aneurysm Market – Spain
- 7.4.7.1. Spain: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.4.7.2. Spain: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.4.8. Intracranial Aneurysm Market – Netherlands
- 7.4.8.1. Netherlands: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.4.8.2. Netherlands: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.4.9. Intracranial Aneurysm Market – Russia
- 7.4.9.1. Russia: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.4.9.2. Russia: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.4.10. Intracranial Aneurysm Market – Rest of Europe
- 7.4.10.1. Rest of Europe: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.4.10.2. Rest of Europe: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.5. Intracranial Aneurysm Market – Asia Pacific
- 7.5.1. Asia Pacific: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.5.2. Asia Pacific: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.5.3. Intracranial Aneurysm Market – China
- 7.5.3.1. China: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.5.3.2. China: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.5.4. Intracranial Aneurysm Market – India
- 7.5.4.1. India: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.5.4.2. India: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.5.5. Intracranial Aneurysm Market – Malaysia
- 7.5.5.1. Malaysia: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.5.5.2. Malaysia: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.5.6. Intracranial Aneurysm Market – Japan
- 7.5.6.1. Japan: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.5.6.2. Japan: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.5.7. Intracranial Aneurysm Market – Indonesia
- 7.5.7.1. Indonesia: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.5.7.2. Indonesia: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.5.8. Intracranial Aneurysm Market – South Korea
- 7.5.8.1. South Korea: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.5.8.2. South Korea: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.5.9. Intracranial Aneurysm Market – Australia
- 7.5.9.1. Australia: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.5.9.2. Australia: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.5.10. Intracranial Aneurysm Market – Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.5.10.2. Rest of Asia Pacific: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.6. Intracranial Aneurysm Market – Middle East & Africa
- 7.6.1. Middle East & Africa: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.6.2. Middle East & Africa: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.6.3. Intracranial Aneurysm Market – Saudi Arabia
- 7.6.3.1. Saudi Arabia: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.6.3.2. Saudi Arabia: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.6.4. Intracranial Aneurysm Market – UAE
- 7.6.4.1. UAE: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.6.4.2. UAE: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.6.5. Intracranial Aneurysm Market – Israel
- 7.6.5.1. Israel: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.6.5.2. Israel: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.6.6. Intracranial Aneurysm Market – South Africa
- 7.6.6.1. South Africa: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.6.6.2. South Africa: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.6.7. Intracranial Aneurysm Market – Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.6.7.2. Rest of Middle East & Africa: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.7. Intracranial Aneurysm Market – Latin America
- 7.7.1. Latin America: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.7.2. Latin America: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.7.3. Intracranial Aneurysm Market – Mexico
- 7.7.3.1. Mexico: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.7.3.2. Mexico: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.7.4. Intracranial Aneurysm Market – Brazil
- 7.7.4.1. Brazil: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.7.4.2. Brazil: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.7.5. Intracranial Aneurysm Market – Argentina
- 7.7.5.1. Argentina: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.7.5.2. Argentina: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 7.7.6. Intracranial Aneurysm Market – Rest of Latin America
- 7.7.6.1. Rest of Latin America: Intracranial Aneurysm Market, by Type, 2020–2034 (USD Million)
- 7.7.6.2. Rest of Latin America: Intracranial Aneurysm Market, by End-Use, 2020–2034 (USD Million)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. B. Braun Melsungen AG
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Integra LifeSciences Corporation (Codman Neuro)
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Johnson & Johnson (CERENOVUS)
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Kaneka Corporation
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Medtronic plc
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. MicroPort Scientific Corporation
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Penumbra, Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Phenox GmbH
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Stryker Corporation
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Terumo Corporation (MicroVention Inc.)
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
